Diabetes & Metabolism Journal

Original Article

Basic and Translational Research
NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9: Xiaolong Li, Yan Cai, Zhu Zhong, Maolin Li, Dong Huang, Zhifei Qiao, Hongli Zhou, Zuo Zhang, Jiyin Zhou; Diabetes Metab J. 2026;50(1):47-61. Published online July 23, 2024; DOI: https://doi.org/10.4093/dmj.2023.0342

5,858 View
188 Download
2 Web of Science
6 Crossref

Background
Disorders of the blood-brain barrier (BBB) arising from diabetes mellitus are closely related to diabetic encephalopathy. Previous research has suggested that neuron-glia antigen 2 (NG2)-glia plays a key role in maintaining the integrity of the BBB. However, the mechanism by which NG2-glia regulates the diabetic BBB remains unclear.
Methods
Type 2 diabetes mellitus (T2DM) db/db mice and db/m mice were used. Evans-Blue BBB permeability tests and transmission electron microscopy techniques were applied. Tight junction proteins were assessed by immunofluorescence and transmission electron microscopy. NG2-glia number and signaling pathways were evaluated by immunofluorescence. Detection of matrix metalloproteinase-9 (MMP-9) in serum was performed using enzyme-linked immunosorbent assay (ELISA).
Results
In T2DM db/db mice, BBB permeability in the hippocampus significantly increased from 16 weeks of age, and the structure of tight junction proteins changed. The number of NG2-glia in the hippocampus of db/db mice increased around microvessels from 12 weeks of age. Concurrently, the expression of MMP-9 increased in the hippocampus with no change in serum. Sixteen- week-old db/db mice showed activation of the Wnt/β-catenin signaling in hippocampal NG2-glia. Treatment with XAV-939 improved structural and functional changes in the hippocampal BBB and reduced MMP-9 secretion by hippocampal NG2-glia in db/db mice. It was also found that the upregulation of β-catenin protein in NG2-glia in the hippocampus of 16-week-old db/db mice was significantly alleviated by treatment with XAV-939.
Conclusion
The results indicate that NG2-glia can lead to structural and functional disruption of the diabetic BBB by activating Wnt/β-catenin signaling, upregulating MMP-9, and degrading tight junction proteins.

Citations

Citations to this article as recorded by

Blood and imaging biomarkers of blood-brain barrier disruption in diabetic individuals with cognitive impairment
Luyao Qiao, Xiaoping Tang, Jiaxing Peng, Qing Xie, Mengqian Wu, Xinyue Chen, Zhenyu Tang
Aging Clinical and Experimental Research.2026;[Epub] CrossRef
Potential role of ghrelin in neuroprotection and cognitive function: implications for diabetic cognitive impairment
Yuhan Zhang, Ruihua Zhang, Xin Wang, Leilei Shi, Hongzhe Zhu, Jiping Liu
PeerJ.2025; 13: e18898. CrossRef
Persisting blood–brain barrier disruption following cisplatin treatment in a mouse model of chemotherapy-associated cognitive impairment
Roland Patai, Boglarka Csik, Adam Nyul-Toth, Rafal Gulej, Kiana Vali Kordestan, Siva Sai Chandragiri, Santny Shanmugarama, Stefano Tarantini, Peter Mukli, Anna Ungvari, Andriy Yabluchanskiy, Zoltan Ungvari, Anna Csiszar
GeroScience.2025; 47(3): 3835. CrossRef
Diabetes Differentially Alters Glial Cells in Different Brain Regions
Rashmi Kumari, Lisa Willing, Patricia J. McLaughlin
Diabetology.2025; 6(3): 16. CrossRef
Quetiapine Reverses the Behavior and Myelination in Alcohol-Exposed Gestational Diabetes Mellitus Offspring Mice via ERK1/2 Signaling
Dong Huang, Maolin Li, Zhifei Qiao, Hongli Zhou, Zuo Zhang, Jiyin Zhou
Biological and Pharmaceutical Bulletin.2025; 48(3): 323. CrossRef
Protection against stroke-induced blood-brain barrier disruption by Guanxinning injection and its active-component combination via TLR4/NF-κB/MMP9-mediated neuroinflammation
Siwen Fan, Hongying Du, Yixin Yao, Huanyi Wang, Min Zhang, Xuliu Shi, Jiankun Yan, Li Peng, Guangxu Xiao, Shuang He, Ming Lyu, Yan Zhu
Phytomedicine.2025; 147: 157162. CrossRef

First
Prev
Page of 1
Next
Last

Search